Close Menu

Clostridium difficile

Meridian's US diagnostics sales plummeted 26 percent, while European diagnostics sales fell about 6 percent and its life science business rose 59 percent, compared to a year ago.

Meridian maintained its guidance for fiscal year 2011 based in part on the gradual uptake of its Illumigene amplification-based C. difficile test and positive contributions from its recently acquired Bioline business.

Meridian wins Canadian regulatory approval for C. difficile test.

The illumigene C. difficile assay detects the presence of the toxin-producing region from the bacterium and provides highly accurate results in under an hour, according to Meridian.

The school will use the NIH money to study the genetics involved in how the pathogen infects people and how it interacts with the gut microbiota.

Asuragen, Life Tech launch BCR/ABL1 Quant test in Europe; Palex Medical to distribute Molecular Detection’s MRSA assay in Spain; Meridian Biosciences gets FDA nod for C. difficile molecular amplification assay.

The illumigene C. difficile molecular amplification test is Meridian's first molecular diagnostic product.

Molecular Detection's Detect-Ready MRSA test; Diatherix Laboratories' GI panel; DNA test for early Lyme disease at Connecticut's Milford Hospital

Meridian Bioscience's Illumigene C. difficile test; Nanosphere's Verigene SP respiratory virus panel; Veredus Laboratories' VereFlu test and VereID Biosystem; and IMDx's 2009 influenza H1N1 assay

The C. difficile test is the first molecular diagnostic product for Meridian. It hopes to market the test later this year.

Pages

In PLOS this week: Mycobacterium abscessus linked to gastric conditions, placental gene expression changes associated with preterm birth, and more.

The Guardian reports that UK universities are looking into ways to reduce labs' reliance on single-use plastics.

People with certain gene variants tend to not like vegetables, particularly bitter ones, CNN reports.

MIT's Technology Review reports on a company's genetic test that gauges an embryo's susceptibility to certain diseases.